BIO-key International, Inc. cash flow to debt ratio of -662.70% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

BIO-key International, Inc.'s free cash flow has decreased 59.71% from $-2.93M last year to $-4.67M, signaling decreasing performance

BIO-key International, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.

BIO-key International, Inc.'s debt has decreased relative to shareholder equity from 0.47 last year to 0.01 today, signaling strengthened financials

BIO-key International, Inc. has a net cash position, so leverage is healthy.

BIO-key International, Inc.'s interest coverage ratio is -19.79, which means that the company struggles to meet interest obligations, signaling financial risk.

BIO-key International, Inc.'s profit margin has increased (-2.38%) in the last year from -62.06% to -60.58%, signaling increasing performance

BIO-key International, Inc.'s short-term assets of $4.60M exceed its short-term liabilities of $3.10M

BIO-key International, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

BIO-key International, Inc.'s return on equity of -57.42%, is lower than 15.00%, indicating bad performance

BIO-key International, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

BIO-key International, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

BIO-key International, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

BIO-key International, Inc. has negative free cash flow, indicating cash burn

BIO-key International, Inc.'s yearly earnings has decreased 6.74% since last year from $-4.30M to $-4.59M, signaling decreasing performance

BIO-key International, Inc.'s yearly revenue has decreased 12.04% since last year from $6.93M to $6.10M, signaling decreasing performance

ROIC -49.59% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

BIO-key International, Inc.'s 3-year revenue CAGR of -4.60% is negative, indicating declining revenue over the past 3 years

BIO-key International, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

BIO-key International, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

BIO-key International, Inc. has insufficient data to evaluate this check.

BIO-key International, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

BIO-key International, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

BIO-key International, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

BIO-key International, Inc. is overvalued relative to its fair value price of -171.47 based on Earnings Fair Value model

BIO-key International, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

BIO-key International, Inc. has a price-to-book ratio of 0.37x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

BIO-key International, Inc. has a price-to-sales ratio of 0.42x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue